Pretreatment of the gerbil brain with a 2-min period of sublethal ischemia protects against neuronal damage following a subsequent 3-min period of ischemia, which normally destroys pyramidal neurons in the CA. region of the hippocampus. To clarify the role of super oxide dismutase (SOD) in this ischemic tolerance, we im munohistochemically investigated the alterations in cop per-zinc SOD (CuZnSOD) and manganese SOD (Mn SOD) in the gerbil hippocampus following 3-min ischemia with or without the first mild ischemia. Normal hippo campus showed an intense CuZnSOD immunostaining in pyramidal neurons but relatively less MnSOD immuno staining. MnSOD, but not CuZnSOD, immunoreactivity increased after the first ischemia. Both CuZnSOD and MnSOD immunoreactivities decreased throughout the Abbreviations used: GFAP, glial fibrillary acidic protein; HSP, heat shock protein; PBS, phosphate-buffered saline; SOD, su peroxide dismutase.
Neurons in specific brain regions are selectively vulnerable to ischemia (Kirino, 1982; Pulsinelli et aI., 1982; Wieloch, 1985; Araki et aI., 1989) . Pyra midal neurons in the CAl subfield of the hippocam pus are so susceptible that only a 3-min period of ischemia damages them in Mongolian gerbils (Kato et aI. , 1991) . However, pretreatment of the brain with a 2-min period of sublethal ischemia followed by 1-7 days of reperfusion protects against the CAl neuronal damage following subsequent ischemia (Kitagawa et aI., 1990a; Kato et aI., 1991; Kirino et hippocampus 4 h after 3 min of ischemia both with and without the first ischemia. The immunostaining recovered in resistant regions (CA3 and dentate gyrus) after 1 day in both groups and in the pretreated CAl after 2 days. With out pretreatment, however, the immunostaining never re covered in the vulnerable CAl region. The results suggest that ischemic tolerance is induced in part by enhanced synthesis of MnSOD in the tolerance-acquired hippocam pus. Both CuZnSOD and MnSOD immunoreactivities de creased after the second ischemia even in the pretreated hippocampus in the early reperfusion periods, but isch emic tolerance facilitated the recovery from the postisch emic reductions in SOD immunoreactivity. Key Words: Cerebral ischemia-Hippocampus-Immunohistochem istry-Ischemic tolerance-Superoxide dismutase.
aI. , 1991). This phenomenon has been termed "ischemic tolerance" and has received attention because the elucidation of its mechanism may pro vide a clue for neuroprotection against ischemic brain damage. Heat shock/stress proteins have been demonstrated in the pretreated hippocampus, and their induction has been suggested to play an im portant role in ischemic tolerance (Kirino et aI. , 1991; Liu et aI. , 1993b; Kato et aI., 1994) . However, the mechanisms of ischemic tolerance remain elu sive.
Oxygen-derived free radicals are generated dur ing and after cerebral ischemia and have been sug gested to play a critical role in ischemia-induced neuronal damage (Hall, 1989; Siesj6 et aI., 1989; Haba et aI., 1991; Sakamoto et aI., 1991; Siesj6 and Katsura, 1992; Chan et aI., 1993; Watson, 1993) . Furthermore, treatment with free radical scaven gers, including exogenous superoxide dismutase (SOD), prevents neuronal damage following cere bral ischemia (Kitagawa et aI., 1990b; Chan, 1992; Uyama et aI., 1992; Hall, 1993) . However, the role of free radicals and their endogenous scavengers in ischemic tolerance remains to be elucidated. We therefore investigated immunohistochemically the alterations of cytosolic copper-zinc SOD (CuZn SOD) and mitochondrial manganese SOD (MnSOD) in the hippocampus following ischemia using a ger bil model of ischemic tolerance.
MATERIALS AND METHODS

Induction of ischemia
Male Mongolian gerbils (Seiwa Experimental Animals, Fukuoka, Japan), 12-13 weeks old and weighing 65-85 g, were used. The animals were anesthetized with 2% halo thane in a mixture of 30% oxygen and 70% nitrous oxide, and both common carotid arteries were gently exposed. One minute after discontinuation of anesthesia, the arter ies were occluded with aneurysm clips for 2 min (the first mild ischemia). When the animals regained consciousness and righting reflex, they were returned to their cages. Three days after 2 min of ischemia or sham operation, the carotid arteries were again occluded for 3 min (the second ischemia) in the same way as the first ischemia was in duced. Body temperature during surgery and ischemia was maintained at 37°C using a heating pad and a lamp. The occurrence of postischemic hyperthermia above 38°C was confirmed in every animal (Kato et aI., 1991) . The animals were killed 3 days after 2 min of ischemia (the first ischemia only) or sham operation and at 4 h, 1 day, 2 days, and 7 days after 3 min of ischemia with and with out the first ischemia. The animals were anesthetized with pentobarbital (50 mg/kg i.p.) and the brains were perfusion-fixed with 4% paraformaldehyde in 0.1 M phos phate buffer (pH 7.4) following a heparinized saline flush. The removed brains were postfixed in the same fixative overnight at 4°C. Then the brains were routinely embed ded in paraffin. Paraffin sections, 5 11m in thickness, were prepared and used for immunohistochemistry. Each group consisted of five animals.
Immunohistochemistry
The sections were deparaffinized and rinsed in 0.01 M phosphate-buffered saline (PBS; pH 7.2). The sections were then preincubated with 10% normal goat serum in PBS for 30 min, followed by overnight incubation at 4°C with an antibody (2 Ilg IgG/ml) against rat CuZnSOD or MnSOD raised in rabbits, 10% normal serum, and 0.3% Triton-XI00 in PBS. The characteristics, specificity, and preparation of the antibodies have been described else where (Kurobe et aI., 1990; Kurobe and Kato, 1991) . The sections were then incubated with biotinylated anti-rabbit IgG antibody (1 :200) and then with avidin-biotin peroxidase complex using a Vectastain elite ABC kit (Vector Laboratories) according to the supplier's recom mendations. Finally, the sections were reacted with 1 mg/ ml diaminobenzidine tetrahydrochloride in 0.05 M Tris HCI buffer (pH 7.6) containing 0.02% H202• Control for nonspecific staining was evaluated by deletion of the pri mary antibody. In this study, nonspecific staining was seen in the white matter but not in the hippocampus. The intensity of the SOD immunoreactivity was semiquanti tatively graded using a scale with 0 (no staining), 1 (weak staining), 2 (moderate staining), and 3 (intense staining). The scores were statistically analyzed with the Kruskal Wallis nonparametric analysis of variance followed by the Wilcoxon rank sum test. Some brain sections were also used for immunohisto chemical staining with anti-glial fibrillary acidic protein (anti-GF AP) antibody (1 :200; Chemic on) for the visual ization of astrocytes essentially as described and for lec tin histochemistry with B4 isolectin from Griffonia sim plicifolia seeds (20 fLg/ml; Sigma) for the visualization of microglia as reported previously (Streit, 1990) .
RESULTS
CuZnSOD immunostaining
In normal gerbil hippocampus, an intense CuZn SOD immunoreactivity was seen in the cytoplasm of pyramidal neurons and interneurons in the CAl and CA3 regions and the dentate hilus, but the stain ing was moderate in dentate granule cells (Figs. la and 2a). Scattered glial cells were also stained. Pre treatment with 2 min of ischemia followed by 3 days of reperfusion caused no discernible changes in the CuZnSOD immunoreactivity in the hippocampus (Figs. Ib and 2b). Four hours after 3 min of isch emia, the immunoreactivity decreased throughout the hippocampus, particularly in CAl neurons both with and without the first ischemia (Figs. lc,d and 2c,d). One day after the second ischemia, the CuZn SOD immunoreactivity in CA3 neurons and dentate granule cells recovered in both groups (Fig. le,f ), but the immunostaining in the CAl and the inner blade of the dentate gyrus was still reduced ( Fig. 2e and f and Fig. 3 ). After 2 days, the staining in the CAl neurons returned to control levels in animals with the first ischemia (Figs. Ih and 2h) but never recovered in animals without the first ischemia (Figs. Ig and 2g). After 7 days, the hippocampus of pretreated animals appeared similar to controls (Figs. Ij and 2j). In animals without the first isch emia, however, destruction of CAl pyramidal neu rons was observed together with an accumulation of reactive glial cells immunostained against CuZn SOD mostly in the dendritic fields (Figs. Ii and 2i). Semiquantitative scores of the immunoreactivities are summarized in Table 1 .
MnSOD immunostaining
In normal gerbil hippocampus, an intense Mn SOD immunoreactivity with a granular staining pat tern was seen in the cytoplasm of scattered inter neurons (Figs. 4a and Sa). The staining was moder ate in the cytoplasm of CA3 pyramidal neurons and the dentate granule cells, but was relatively weak in CAl pyramidal neurons (Figs. 4a and 5a). Scattered glial cells were also stained weakly. Pretreatment Immunostaining against copper-zinc superoxide dismutase (CuZnSOD) in the gerbil hippocampus. In sham-operated animals (a) and 3 days after 2 min of ischemia (b), no definite changes are seen. Four hours after 3 min of ischemia without (c) and with (d) pretreatment with 2 min of ischemia and 3 days of reperfusion, CuZnSOD staining is decreased throughout the hippocampus. One day after 3-min ischemia without (e) and with (f) the first ischemia, CuZnSOD immunostaining recovered in CA3 and the dentate gyrus, but not in CA1• Two days after 3-min ischemia, the staining in CA1 recovered in animals with the first ischemia (h) but not without the first ischemia (g). In animals without the first ischemia (i), CA1 pyramidal neurons had been destroyed after 7 days and reactive glial cells with CuZnSOD immunostaining accumulated, but the neurons remained intact in animals with the first ischemia (j). Scale bar = 0.5 mm. Immunostaining against copper-zinc superoxide dismutase (CuZnSOD) in the CA1 subfield. No definite changes are seen in sham-operated animals (8) or 3 days after 2 min of ischemia (b), Four hours after 3 min of ischemia without (c) and with (d) pretreatment with 2 min of ischemia and 3 days of reperfusion, CuZnSOD staining is decreased. One day after 3-min ischemia without (e) and with (f) the first ischemia, the immunostaining is still decreased in both groups. Two days after 3-min ischemia without (g) and with (h) the first ischemia, staining in CA1 recovered in animals with the first ischemia (h) but not without it (g). Seven days after 3-min ischemia without the first ischemia (I), but the CA1 neurons appear normal in animals with the first ischemia (j). CA1 pyramidal neurons had been destroyed and reactive glial cells with CuZnSOD immunostaining accumulated (i). Scale bar = 0.1 mm.
FIG. 3.
Immunostaining against copper-zinc superoxide dis mutase (CuZnSOD) in the hippocampus 1 day after 3 min of ischemia with pretreatment with 2 min of ischemia. a: The transition between CA1 and CA3 subfields. CuZnSOD immu nostaining is intense in CA3 pyramidal neurons (right side) but markedly reduced in CA1 pyramidal neurons (left side). b: Dentate gyrus. The immunostaining in the inner blade of the dentate gyrus is decreased (arrowheads). Scale bar = 0.1 mm (a) and 0.2 mm (b).
with 2 min of ischemia followed by 3 days of reper fusion caused an increase in the MnSOD immuno reactivity in many CAl and CA3 pyramidal neurons and in glial cells mostly in the stratum lacunosum moleculare of the CAl subfield and the dentate mo lecular layer (Figs. 4b, Sb, and 6d). Four hours after 3 min of ischemia, the MnSOD immunoreactivity decreased in CA I both with and without the first ischemia (Figs. 4c, d and Sc, d) . However, glial cells were stained in the hippocampus without pretreat ment. One day after the second ischemia, the neu ronal immunoreactivity in the CA3 subfield and the dentate gyrus recovered and even increased in both groups, and MnSOD-immunoreactive glial cells were observed throughout the hippocampus (Figs. 4e,f, Se,f, and 6). After 2 days, the immunostaining in the CAl neurons recovered and even increased in the pretreated hippocampus (Figs. 4h and Sh) but never recovered in animals without the first isch emia (Figs. 4g and Sg). After 7 days, the hippocam pus of pretreated animals appeared similar to con trols (Figs. 4j and Sj). However, destruction of CAl neurons and accumulation of reactive glial cells with intense MnSOD immunoreactivity were seen J Cereb Blood Flow Metab, Vol. 15, No.1, 1995 in the CAl' in both the pyramidal cell layer and the dendritic fields, of animals without the first isch emia (Figs. 4i and Si) . Semiquantitative scores of the immunoreactivities are summarized in Table 1 .
Glial staining
Seven days after 3 min of ischemia without the first ischemia, an accumulation of reactive glial cells was observed in the CAl subfield. The distri bution and morphology of astrocytes as visualized by GF AP immunostaining were different from those of microglia as visualized by lectin staining. GF AP positive astrocytes were localized in the strata la cunosum-moleculare, oriens, and radiatum, but were absent in and around the stratum pyramidale (Fig. 7a) . In contrast, microglial cells were accumu lated most in the stratum pyramidale as well as in strata radiatum and oriens (Fig. 7b ). Astrocytes had rounded nuclei and slender processes, whereas mi croglia had smaller elongated or oval nuclei and ramified thin processes.
Both CuZnSOD and MnSOD were intensely stained in the reactive glial cells. Perikarya and pro cesses were stained for MnSOD but predominantly perikarya for CuZnSOD. The distribution and mor phology of CuZnSOD-positive glial cells were mostly those of astrocytes, but those with micro glial morphology were also observed ( Fig. 7c ). Mn SOD-positive glial cells had the morphology and distribution of both astrocytes and microglia (Fig.  7d) .
DISCUSSION
As the present study showed, CuZnSOD was constitutively produced in the gerbil hippocampus, but the MnSOD immunostaining was relatively weak in pyramidal neurons. However, MnSOD was inducible after ischemic insult. The increased Mn SOD immunostaining was observed in CAl and CA3 neurons after the first mild ischemia. MnSOD also increased in CAl and CA3 neurons after the second ischemia in pretreated animals. However, an in crease in CuZnSOD immunostaining was not dis cernible in this study, although Matsuyama et al. (1993) observed it following a longer period of isch emia in gerbils. Because the generation of oxygen derived free radicals has been proposed as a critical factor in ischemia-induced neuronal damage (Siesjo, 1981; Siesjo et al. , 1989; Hall, 1993; Wat son, 1993) , the increase in MnSOD may play a pro tective role in the development of ischemic toler ance and the survival of neurons after ischemia.
An increase in MnSOD immunostaining was also seen in glial cells in the pretreated hippocampus and in the early reperfusion periods after the second ischemia. The increase in glial SOD may reflect an early and generalized glial activation after ischemia. Following destruction of CAl neurons, reactive glial cells accumulated in the CAl region at 7 days. The reactive glial cells had intense immunoreactivities to both CuZnSOD and MnSOD. Comparison with GF AP immunostaining and lectin staining showed that these reactive glial cells with SOD immuno staining were both astrocytes and microglia. The SOD in glial cells may protect them against isch emic injury.
The induction of the mitochondrial enzyme Mn SOD has been shown after oxidative and other stresses (Hassan, 1988; Ohtsuki et aI. , 1992) . It has also been reported that cerebral and cardiac isch emia induces MnSOD expression (Hoshida et aI., 1993; Ohtsuki et a1., 1993) . Therefore, the MnSOD induction observed in this study may be triggered by ischemia-induced oxidative stress or some other ischemia-induced mechanisms. A 2-min occlusion of bilateral carotid arteries in gerbils produces nearly complete ischemia in the forebrain (Kato et aI. , 1991) . This length of brief ischemia is sublethal but is stressful enough to induce neuronal changes such as postischemic hypoperfusion (Kato et aI., 1991) , transient suppression of protein synthesis (Araki et aI., 1991) , and induction of stress proteins (Kirino et aI., 1991) . The level of cerebral blood flow after the second ischemia has not been studied. However, a microdialysis study as mentioned in the following suggested that the second ischemia in pre treated animals was as severe as in animals without the first ischemia. Thus, the increased SOD staining may be in response to ischemic stress.
Both CuZnSOD and MnSOD immunoreactivities decreased in the hippocampal neurons in the early reperfusion periods after the second ischemia, even in the pretreated animals in which CAl neurons could survive because of ischemic tolerance. The SOD immunoreactivity recovered first in CA3 neu rons and dentate granule cells, which are resistant to ischemia. A similar recovery of the immunoreac tivity followed in the pretreated CAl region. How ever, the immunoreactivity never recovered in the CAl without the first ischemia, in which neuronal death takes place. Similar observations of a de crease in SOD immunostaining before neuronal death occurs have been reported in rats and gerbils (Liu et aI., 1993a; Matsuyama et aI., 1993) . This early loss of SOD may relate to the delayed death of CAl neurons. Thus, the first mild ischemia did not prevent the initial postischemic suppression of SOD immunoreactivity, but ischemic tolerance was asso ciated with facilitated postischemic recovery of CuZnSOD and MnSOD synthesis. Nakagomi et ai. (1993) and our unpublished data have shown that protein synthesis in the CAl takes a similar post ischemic time course. The first mild ischemia does not prevent the initial postischemic suppression of protein synthesis but facilitates postischemic recov-FIG. 4. Immunostaining against manganese superoxide dismutase (MnSOD) in the gerbil hippocampus. An increase in MnSOD staining is seen in CA1 neurons 3 days after 2 min of ischemia (b) as compared with sham-operated animals (8). Four hours after 3 min of ischemia without (c) and with (d) pretreatment with 2 min of ischemia and 3 days of reperfusion, MnSOD staining is decreased in CA1. One day after 3-min ischemia without (e) and with (f) the first ischemia, the staining in CA1 is still decreased in both groups. Immunostaining in CA3 and the dentate gyrus is increased (e). Two days after 3-min ischemia without (9) and with (h) the first ischemia, staining in CA1 recovered in animals with the first ischemia (h) but not without it (g). Seven days after 3-min ischemia without the first ischemia (i), CA1 pyramidal neurons had been destroyed and reactive glial cells with intense MnSOD immunostaining accumulated (i), but CA1 neurons appear normal in animals with the first ischemia 0). Scale bar = 0.5 mm.
FIG. 5.
Immunostaining against manganese superoxide dismutase (MnSOD) in the CA1 subfield. An increase in MnSOD staining is seen in CA1 neurons 3 days after 2 min of ischemia (b) as compared with sham-operated animals (a). Four hours after 3 min of ischemia without (c) and with (d) pretreatment with 2 min of ischemia and 3 days of reperfusion, MnSOD staining decreased in neurons but increased in glial cells (c). One day after 3-min ischemia without (e) and with (1) the first ischemia, immunostaining in neurons is still decreased in both groups. Two days after 3-min ischemia without (g) and with (h) the first ischemia, staining in CA1 recovered and increased in animals in the latter group (h) but not in the former (g). Seven days after 3-min ischemia without the first ischemia (I), CA1 pyramidal neurons had been destroyed and reactive glial cells with intense MnSOD immuno staining accumulated, but CA1 neurons appear normal in animals with the first ischemia (j). Scale bar = 0.1 mm.
FIG. 6. Immunostaining against manganese superoxide dismutase (MnSOD). a: CA3 subfield of a sham-operated animal. b: CA3 subfield of an animal 1 day after 3 min of ischemia with pretreatment with 2 min of ischemia. MnSOD immunostaining increased in many CA3 pyramidal neurons (arrows) compared with control (a). o-f: Dentate gyrus of a sham-operated animal (c), 3 days after 2 min of ischemia (d), and at 1 day after 3 min of ischemia without (e) and with (f) the first ischemia. Note an increase in glial MnSOD immunostaining in pretreated brain (d,f) and increased MnSOD staining in dentate granule cells and CA3 neurons (e) (arrow). Scale bar = 0. 1 mm (b) and 0.2 mm (f). ery of protein synthesis. Therefore, the reduced SOD immunoreactivity in the early reperfusion pe riods might be associated with this suppressed pro tein synthesis. However, it is equally possible that their restored expression is a consequence rather than the cause of survival.
The present observation of a transient decrease in SOD immunoreactivity in the CAl neurons in ani mals with the first mild ischemia suggests that the ischemic tolerance does not ameliorate the initial ischemic injury. This finding may be in accordance with our previous observations as follows: (a) Pre treatment with the first mild ischemia did not alter the amount of excitatory and inhibitory amino acids released during the second ischemia as shown by J Cereb Blood Flow Metab, Vol. 15, No. 1, 1995 intracerebral microdialysis (Nakata et aI. , 1992; Kato et aI., 1993) . Because the abnormal release of excitotoxic amino acids during ischemia is generally accepted as an initial event that leads to ischemic neuronal damage through N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor mediated excitotoxicity (Rothman and Olney, 1986; Choi, 1990) , this observation demonstrates that the sever ity of the second ischemia per se is not reduced by the first mild ischemia. (b) Immunostaining against ubiquitin, a small heat shock protein (HSP) , initially disappereared in the hippocampus after 3-min isch emia both with and without the first ischemia, but the immunoreactivity first recovered in the CA3 and the dentate gyrus, followed by the pretreated CAl' FIG. 7. CA1 subfield of the hippocam pus 7 days after 3 min of ischemia without pretreatment with 2 min of ischemia. a: Glial fibrillary acidic pro tein immunostaining for the visualiza tion of astrocytes. b: Lectin histo chemistry for the visualization of mi croglia (arrows). c: Copper-zinc superoxide dismutase immunostain ing. d: Manganese superoxide dismu tase immunostaining. 0, stratum oriens; p, stratum pyramidale; r, stra tum radiatum. Scale bar = 0.05 mm.
However, ubiquitin immunoreactivity never recov ered in the CAl of animals without the first ischemia (Kato et aI., 1993) . Thus, the postischemic alter ations in ubiquitin immunoreactivity were very sim ilar to those of the SOD immunostaining.
The findings that SOD immunoreactivity de creased during early reperfusion periods even in the pretreated hippocampus suggest that ischemic tol erance requires additional protective factors other than a recovery of SOD. Previous reports showed that oxygen-derived free radicals were generated during and immediately after ischemia (Kitagawa et aI., 1990b; Haba et ai., 1991) . During these periods, constitutive CuZnSOD and induced MnSOD in tol erance-acquired hippocampus may substantially quench the generated free radicals. However, it is possible that SOD is not the sole mechanism that operates against oxygen toxicity. J oenje et al. (1985) reported that a strain of HeLa cells were tol erant to 80% oxygen that quickly damaged normal cells and that the oxygen-tolerant cells showed no increase in SOD, catalase, or glutathione peroxi dase activities. They suggested that cells might have an increased resistance to radical attack by using other mechanisms.
An additional explanation of ischemic tolerance may include activation of HSP genes by ischemia. HSP70 has been shown to increase dramatically in the tolerance-acquired hippocampus (Kirino et aI. , 1991; Liu et aI., 1993b) . HSP70 may exhibit a pro tective effect by maintaining the tertiary structure of normal or partially denatured proteins produced by ischemia (Lindquist, 1986) . HSP27 is also in duced in the tolerance-acquired hippocampus, pre dominantly in glial cells, and is possibly related to the ischemic tolerance through neuron-glia interac tions (Kato et aI., 1994) . Both HSP70 and HSP27 have been shown to induce thermotolerance in vitro, a transient resistance to heat induced by ex-posure to high temperature (Chretien and Landry, 1988; Johnston and Kucey, 1988; Riabowol et aI., 1988; Landry et aI. , 1989) . However, the temporal correlation between ischemic tolerance and HSP in duction does not necessarily imply a cause-and effect relationship, and further studies are neces sary.
In conclusion, our study of neuronal protection by the first mild ischemia suggests that part of the protective mechanisms is related to the induction of MnSOD in the tolerance-acquired hippocampus. Recovery of the antioxidant system (CuZnSOD and MnSOD) after ischemia was also facilitated in ani mals with the first ischemia and may play a role. However, the nature of the factors that respond so dramatically to the first ischemia may involve an activation of multiple different systems. Their elu cidation is of considerable importance for the un derstanding of the mechanisms of ischemic toler ance and deserves further investigation.
